Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Thrombocytopenia 1CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Interventional × oprelvekin × Clear all
NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
88 enrolled
Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

NCT01663441 2020-09-16

A Phase â…¢a Study of Genetically Modified Recombinant Human Interleukin-11

Beijing Northland Biotech. Co., Ltd.

Phase 3 Completed
62 enrolled
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡